Expert review of clinical pharmacology

Keyphrases

Publications

volume 17, number 5-6, 2024

Di Xiao, Zhiyun Yang, Yin Shi, Wenqing Yang, Yu Zhang
Is a low dose of dexamethasone sufficient to prevent paclitaxel-related hypersensitivity reactions? A retrospective study in patients with gynecologic malignancy. Expert review of clinical pharmacology 17 (5-6) (2024)
Yun Han Chen, Anastasios Xenitidis, Paul Hoffmann, Leslie Matthews, Swathi G Padmanabhan, Lakshmi Aravindan, Ruth Ressler, Inesh Sivam, Sahana Sivam, Chase F Gillispie, Senthilkumar Sadhasivam
Opioid use disorder in pediatric populations: considerations for perioperative pain management and precision opioid analgesia. Expert review of clinical pharmacology 17 (5-6) (2024)
Maurlia D Upchurch, Benyam Muluneh
Treatment adherence and adverse event management in chronic lymphocytic leukemia: challenges and strategies for the future. Expert review of clinical pharmacology 17 (5-6) (2024)
Barbara Farrell
Engaging patients in conversations about deprescribing. Expert review of clinical pharmacology 17 (5-6) (2024)
Yafang Huang, Jinqiu Yuan
Improvement of assessment in surrogate endpoint and safety outcome of single-arm trials for anticancer drugs. Expert review of clinical pharmacology 17 (5-6) (2024)
Ahmad Vafaeian, Hamidreza Mahmoudi, Maryam Daneshpazhooh
What is novel in the clinical management of pemphigus vulgaris? Expert review of clinical pharmacology 17 (5-6) (2024)
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review. Expert review of clinical pharmacology 17 (5-6) (2024)
Kannan Sridharan, Gowri Sivaramakrishnan
Genito-urinary infectious adverse events related to sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression. Expert review of clinical pharmacology 17 (5-6) (2024)
Emily G McDonald, Carina Lundby, Wade Thompson, Cynthia Boyd, Barbara Farrell, Camille Gagnon, Jennie Herbin, Ninh Khuong, Frank Moriarty, Tiphaine Pierson, Sion Scott, Ian A Scott, Jim Silvius, Anne Spinewine, Michael A Steinman, Cara Tannenbaum, Johanna Trimble, Justin P Turner, Emily Reeve
Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks. Expert review of clinical pharmacology 17 (5-6) (2024)
Béni Ntobe-Bunkete, Florian Lemaitre
Therapeutic drug monitoring in kidney and liver transplantation: current advances and future directions. Expert review of clinical pharmacology 17 (5-6) (2024)
Yun Han Chen, Anastasios Xenitidis, Paul Hoffmann, Leslie Matthews, Swathi G Padmanabhan, Lakshmi Aravindan, Ruth Ressler, Inesh Sivam, Sahana Sivam, Chase F Gillispie, Senthilkumar Sadhasivam
Opioid use disorder in pediatric populations: considerations for perioperative pain management and precision opioid analgesia. Expert review of clinical pharmacology 17 (5-6) (2024)
Panagiotis I Georgianos, Vasilios Vaios, Ioannis Kontogiorgos, Maria Divani, Vassilios Liakopoulos
The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease. Expert review of clinical pharmacology 17 (5-6) (2024)
Béni Ntobe-Bunkete, Florian Lemaitre
Therapeutic drug monitoring in kidney and liver transplantation: current advances and future directions. Expert review of clinical pharmacology 17 (5-6) (2024)
Yafang Huang, Jinqiu Yuan
Improvement of assessment in surrogate endpoint and safety outcome of single-arm trials for anticancer drugs. Expert review of clinical pharmacology 17 (5-6) (2024)
Ahmad Vafaeian, Hamidreza Mahmoudi, Maryam Daneshpazhooh
What is novel in the clinical management of pemphigus vulgaris? Expert review of clinical pharmacology 17 (5-6) (2024)
Simona Lattanzi, Eugen Trinka, Stefano Meletti, Pasquale Striano, Sara Matricardi, Mauro Silvestrini, Francesco Brigo
A profile of azetukalner for the treatment of epilepsy: from pharmacology to potential for therapy. Expert review of clinical pharmacology 17 (5-6) (2024)

volume 17, number 7, 2024

Sai Santhosha Mrudula Alla, Dhruv J Shah, Vysakh Ratheesh, Deekshitha Alla, Thanmayee Tummala, Moksh S Khetan, Ritika J Shah, Ruth G Bayeh, Mahek Fatima, Sanah K Ahmed, Mert Sabıroğlu
Effectiveness of statins in people living with HIV: a systematic review and meta-analysis of randomized controlled trials. Expert review of clinical pharmacology 17 (7) (2024)
Rebecca Y Linfield, Nancy N Nguyen, Olivia H Laprade, Mark Holodniy, Aarthi Chary
An update on drug-drug interactions in older adults living with human immunodeficiency virus (HIV). Expert review of clinical pharmacology 17 (7) (2024)
Nicole F Maranchick, Awewura Kwara, Charles A Peloquin
Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics. Expert review of clinical pharmacology 17 (7) (2024)
Dario Cattaneo, Cristina Gervasoni
Therapeutic drug monitoring of antiretroviral therapy: current progresses and future directions. Expert review of clinical pharmacology 17 (7) (2024)
Analuz Fernández, Arkaitz Imaz
Clinical considerations when switching antiretroviral therapy. Expert review of clinical pharmacology 17 (7) (2024)
Dongsheng Li, Ran Xiao, Qiang Fu, Xiaojing Song, Yang Han, Xiaoli Du, Taisheng Li
A preliminary study on plasma concentration, short-term efficacy, and safety profile of dolutegravir in Chinese people with HIV. Expert review of clinical pharmacology 17 (7) (2024)
Ahmad Z Al Meslamani
Antiretroviral therapy response: exploring the potential influence of SARS-CoV-2. Expert review of clinical pharmacology 17 (7) (2024)
Dongsheng Li, Ran Xiao, Qiang Fu, Xiaojing Song, Yang Han, Xiaoli Du, Taisheng Li
A preliminary study on plasma concentration, short-term efficacy, and safety profile of dolutegravir in Chinese people with HIV. Expert review of clinical pharmacology 17 (7) (2024)
Sai Santhosha Mrudula Alla, Dhruv J Shah, Vysakh Ratheesh, Deekshitha Alla, Thanmayee Tummala, Moksh S Khetan, Ritika J Shah, Ruth G Bayeh, Mahek Fatima, Sanah K Ahmed, Mert Sabıroğlu
Effectiveness of statins in people living with HIV: a systematic review and meta-analysis of randomized controlled trials. Expert review of clinical pharmacology 17 (7) (2024)
Adati Tarfa, Audun J Lier, Sheela V Shenoi, Sandra A Springer
Considerations when prescribing opioid agonist therapies for people living with HIV. Expert review of clinical pharmacology 17 (7) (2024)
Rebecca Y Linfield, Nancy N Nguyen, Olivia H Laprade, Mark Holodniy, Aarthi Chary
An update on drug-drug interactions in older adults living with human immunodeficiency virus (HIV). Expert review of clinical pharmacology 17 (7) (2024)
Adati Tarfa, Audun J Lier, Sheela V Shenoi, Sandra A Springer
Considerations when prescribing opioid agonist therapies for people living with HIV. Expert review of clinical pharmacology 17 (7) (2024)

volume 17, number 8, 2024

Sherifa Ahmed Hamed, Ali Farrag El Hadad
The effect of anticholinergic drugs on cognition of patients with Parkinson's disease: a cohort study from the Egyptian population. Expert review of clinical pharmacology 17 (8) (2024)
Noemi Milan, Federico Navarria, Erika Cecchin, Elena De Mattia
Somatic pharmacogenomics in the treatment prognosis of locally advanced rectal cancer patients: a narrative review of the literature. Expert review of clinical pharmacology 17 (8) (2024)
Wan-Chuan Tsai, Yu-Sen Peng, Hon-Yen Wu
The risk of genito-urinary infections with sodium-glucose cotransporter-2 inhibitors: duration rather than dose matter? Expert review of clinical pharmacology 17 (8) (2024)
Denise Li, Susannah Franco, Page B Pennell
The impact of pregnancy-related hormonal and physiological changes on antiseizure medications: expert perspective. Expert review of clinical pharmacology 17 (8) (2024)
Giovanni Corona, Giulia Rastrelli, Clotilde Sparano, Linda Vignozzi, Alessandra Sforza, Mario Maggi
Pharmacological management of testosterone deficiency in men current advances and future directions. Expert review of clinical pharmacology 17 (8) (2024)
Neslihan Akdogan, Kerem Balan, Basak Yalici Armagan, Duygu Gülseren, Sibel Dogan Gunaydin
Psoriatic arthritis, biologic therapy experience, body mass index, and onset age of psoriasis were independent factors of secukinumab discontinuation in patients with psoriasis. Expert review of clinical pharmacology 17 (8) (2024)
Neslihan Akdogan, Kerem Balan, Basak Yalici Armagan, Duygu Gülseren, Sibel Dogan Gunaydin
Psoriatic arthritis, biologic therapy experience, body mass index, and onset age of psoriasis were independent factors of secukinumab discontinuation in patients with psoriasis. Expert review of clinical pharmacology 17 (8) (2024)
Petra Denig, Peter J C Stuijt
Perspectives on deprescribing in older people with type 2 diabetes and/or cardiovascular conditions: challenges from healthcare provider, patient and caregiver perspective, and interventions to support a proactive approach. Expert review of clinical pharmacology 17 (8) (2024)
Kannan Sridharan, Gowri Sivaramakrishnan
Enhancing readability of USFDA patient communications through large language models: a proof-of-concept study. Expert review of clinical pharmacology 17 (8) (2024)
Muhammad Adnan Zaman, Sidra Kalsoom, Warsha Koran
CSL112 and HDL function hypothesis - a never-ending wait. Expert review of clinical pharmacology 17 (8) (2024)
Petra Denig, Peter J C Stuijt
Perspectives on deprescribing in older people with type 2 diabetes and/or cardiovascular conditions: challenges from healthcare provider, patient and caregiver perspective, and interventions to support a proactive approach. Expert review of clinical pharmacology 17 (8) (2024)
Noemi Milan, Federico Navarria, Erika Cecchin, Elena De Mattia
Somatic pharmacogenomics in the treatment prognosis of locally advanced rectal cancer patients: a narrative review of the literature. Expert review of clinical pharmacology 17 (8) (2024)
Sherifa Ahmed Hamed, Ali Farrag El Hadad
The effect of anticholinergic drugs on cognition of patients with Parkinson's disease: a cohort study from the Egyptian population. Expert review of clinical pharmacology 17 (8) (2024)
Muhammad Adnan Zaman, Sidra Kalsoom, Warsha Koran
CSL112 and HDL function hypothesis - a never-ending wait. Expert review of clinical pharmacology 17 (8) (2024)
Yuna Chae, Sun-Hong Kwon, Jin Hyun Nam, Eunsung Kang, Jiae Im, Hyo-Jin Kim, Eui-Kyung Lee
Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis. Expert review of clinical pharmacology 17 (8) (2024)
Wan-Chuan Tsai, Yu-Sen Peng, Hon-Yen Wu
The risk of genito-urinary infections with sodium-glucose cotransporter-2 inhibitors: duration rather than dose matter? Expert review of clinical pharmacology 17 (8) (2024)
Kannan Sridharan, Gowri Sivaramakrishnan
Reply to: The risk for genito-urinary infections with sodium-glucose cotransporter-2 inhibitors: duration rather than dose matter? Expert review of clinical pharmacology 17 (8) (2024)
Kannan Sridharan, Gowri Sivaramakrishnan
Enhancing readability of USFDA patient communications through large language models: a proof-of-concept study. Expert review of clinical pharmacology 17 (8) (2024)
Giovanni Corona, Giulia Rastrelli, Clotilde Sparano, Linda Vignozzi, Alessandra Sforza, Mario Maggi
Pharmacological management of testosterone deficiency in men current advances and future directions. Expert review of clinical pharmacology 17 (8) (2024)
Denise Li, Susannah Franco, Page B Pennell
The impact of pregnancy-related hormonal and physiological changes on antiseizure medications: expert perspective. Expert review of clinical pharmacology 17 (8) (2024)
Yuna Chae, Sun-Hong Kwon, Jin Hyun Nam, Eunsung Kang, Jiae Im, Hyo-Jin Kim, Eui-Kyung Lee
Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis. Expert review of clinical pharmacology 17 (8) (2024)
Kannan Sridharan, Gowri Sivaramakrishnan
Reply to: The risk for genito-urinary infections with sodium-glucose cotransporter-2 inhibitors: duration rather than dose matter? Expert review of clinical pharmacology 17 (8) (2024)